ClinVar Miner

Submissions for variant NM_006939.4(SOS2):c.3088A>G (p.Thr1030Ala)

gnomAD frequency: 0.00010  dbSNP: rs550680554
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000559916 SCV000656023 likely benign Noonan syndrome 9 2023-11-28 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001251388 SCV001426971 likely benign not specified 2020-07-13 criteria provided, single submitter clinical testing Variant summary: SOS2 c.3088A>G (p.Thr1030Ala) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00019 in 240566 control chromosomes. The observed variant frequency is approximately 75 fold of the estimated maximal expected allele frequency for a pathogenic variant in SOS2 causing Noonan Syndrome And Related Conditions phenotype (2.5e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.3088A>G in individuals affected with Noonan Syndrome And Related Conditions and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as likely benign. Based on the evidence outlined above, the variant was classified as likely benign.
Ambry Genetics RCV002325091 SCV002608742 likely benign Cardiovascular phenotype 2022-06-22 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Genome-Nilou Lab RCV000559916 SCV002763008 likely benign Noonan syndrome 9 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV003392402 SCV004134077 benign not provided 2022-08-01 criteria provided, single submitter clinical testing SOS2: BS1, BS2
Breakthrough Genomics, Breakthrough Genomics RCV003392402 SCV005211995 likely benign not provided criteria provided, single submitter not provided
Service de Génétique Moléculaire, Hôpital Robert Debré RCV001261127 SCV001438534 likely benign Noonan syndrome no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.